EcoDrugPlus

Ensembl ID : ENSACIG00000015550
Gene Symbol: VDRB
1 Cross references
394 Possible Orthologues:

Ensembl ID : ENSACIG00000007370
Gene Symbol: PRKCI
1 Cross references
270 Possible Orthologues:

Ensembl ID : ENSACIG00000007139
Gene Symbol: -
Cross references: -
191 Possible Orthologues:

Ensembl ID : ENSACIG00000006595
Gene Symbol: -
Cross references: -
208 Possible Orthologues:

Ensembl ID : ENSACIG00000018610
Gene Symbol: PSEN2
1 Cross references
206 Possible Orthologues:

Ensembl ID : ENSACIG00000020306
Gene Symbol: -
Cross references: -
186 Possible Orthologues:

Ensembl ID : ENSACIG00000005754
Gene Symbol: -
1 Cross references
203 Possible Orthologues:

Ensembl ID : ENSACIG00000005297
Gene Symbol: -
Cross references: -
117 Possible Orthologues:

Ensembl ID : ENSACIG00000005146
Gene Symbol: -
Cross references: -
121 Possible Orthologues:

Ensembl ID : ENSACIG00000004675
Gene Symbol: YES1
1 Cross references
197 Possible Orthologues:

Ensembl ID : ENSACIG00000020009
Gene Symbol: -
Cross references: -
199 Possible Orthologues:

Ensembl ID : ENSACIG00000002041
Gene Symbol: RPL10A
1 Cross references
380 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).